Search

Your search keyword '"Pais, Prem"' showing total 500 results

Search Constraints

Start Over You searched for: Author "Pais, Prem" Remove constraint Author: "Pais, Prem"
500 results on '"Pais, Prem"'

Search Results

3. Tobacco use and risk of acute stroke in 32 countries in the INTERSTROKE study: a case–control study

5. Secondary prevention with a structured semi-interactive stroke prevention package in INDIA (SPRINT INDIA): a multicentre, randomised controlled trial

7. External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry

8. Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial

9. Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis

12. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

13. Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis

15. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

16. Resource and Infrastructure-Appropriate Management of ST-Segment Elevation Myocardial Infarction in Low- and Middle-Income Countries

18. Characteristics, clinical practice patterns and outcomes of strokes in India: INSPIRE - A multicentre prospective study

19. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study

20. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study

21. Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics

23. Tackling NCD in LMIC: Achievements and Lessons Learned From the NHLBI–UnitedHealth Global Health Centers of Excellence Program

26. sj-docx-1-wso-10.1177_17474930231175584 – Supplemental material for Characteristics, clinical practice patterns, and outcomes of strokes in India: INSPIRE—A multicentre prospective study

28. Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial

29. Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide

30. The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges

32. Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE)

33. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

34. Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE)

35. Sleep Patterns and the Risk of Acute Stroke

36. The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial: Results of the Continuous Electrocardiographic Assessment Substudy

37. The cost implications of a polypill for primary prevention in the TIPS-3 trial

38. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

39. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

40. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

42. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study

47. Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants

48. Lowering cholesterol, blood pressure, or both to prevent cardiovascular events : results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants

49. Antihypertensives and Statin Therapy for Primary Stroke Prevention : A Secondary Analysis of the HOPE-3 Trial

50. Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level

Catalog

Books, media, physical & digital resources